RAYZ-8009

N/A

Report date: 2026/05/18 20:02:07

NME

Base Information

Drug NameRAYZ-8009

Drug Alias NameRAYZ-8009RAYZ 8009225Ac-RAYZ-8009[225Ac]Ac-RYZ-GPC3RYZ-801 +[9]

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radionuclide Drug Conjugates +[5]

Mechanisms of ActionAnti-Glypican-3

TargetsGlypican-3

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPeptiDream Inc RayzeBio Inc

China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream Inc

Inactive CompaniesRayzeBio Inc

Active IndicationsCarcinoma, Hepatocellular

Inactive IndicationsN/A

Other Information

ATC CodeN/A